Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Bacille Calmette-Guérin (BCG) Vaccine In Radiologically Isolated Syndrome (RIS) — Stella

Home/Multiple Sclerosis/Bacille Calmette-Guérin (BCG) Vaccine In Radiologically Isolated Syndrome (RIS)

View on ClinicalTrials.gov

Recruiting

Back to Multiple Sclerosis trials

Bacille Calmette-Guérin (BCG) Vaccine In Radiologically Isolated Syndrome (RIS)

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Italy

Center for Experimental Neurological Therapies (CENTERS), S. Andrea Hospital, Faculty of Medicine and Psychology, "Sapienza" University of Rome, Rome

Key details

Phase

Safety & dosing

Sponsor

S. Andrea Hospital

Enrollment target

~100 participants

Started

June 2019

Primary completion

July 2026

Age range

18 Years and older

Last updated November 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.